TY - JOUR
T1 - Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors
AU - Ponzetta, Andrea
AU - Carriero, Roberta
AU - Carnevale, Silvia
AU - Barbagallo, Marialuisa
AU - Molgora, Martina
AU - Perucchini, Chiara
AU - Magrini, E.
AU - Gianni, Francesca
AU - Kunderfranco, P.
AU - Polentarutti, N.
AU - Pasqualini, F.
AU - Di Marco, Sabrina
AU - Supino, Domenico
AU - Peano, Clelia
AU - Cananzi, Ferdinando
AU - Colombo, Piergiuseppe
AU - Pilotti, Silvana
AU - Alomar, Suliman Yousef
AU - Bonavita, Eduardo
AU - Galdiero, Maria Rosaria
AU - Garlanda, Cecilia
AU - Mantovani, Alberto
AU - Jaillon, Sebastien
N1 - Publisher Copyright:
© 2019 The Authors
PY - 2019/7/11
Y1 - 2019/7/11
N2 - Neutrophils are a component of the tumor microenvironment and have been predominantly associated with cancer progression. Using a genetic approach complemented by adoptive transfer, we found that neutrophils are essential for resistance against primary 3-methylcholantrene-induced carcinogenesis. Neutrophils were essential for the activation of an interferon-γ-dependent pathway of immune resistance, associated with polarization of a subset of CD4− CD8− unconventional αβ T cells (UTCαβ). Bulk and single-cell RNA sequencing (scRNA-seq) analyses unveiled the innate-like features and diversity of UTCαβ associated with neutrophil-dependent anti-sarcoma immunity. In selected human tumors, including undifferentiated pleomorphic sarcoma, CSF3R expression, a neutrophil signature and neutrophil infiltration were associated with a type 1 immune response and better clinical outcome. Thus, neutrophils driving UTCαβ polarization and type 1 immunity are essential for resistance against murine sarcomas and selected human tumors. Tumor-associated neutrophils (TANs) have mainly been portrayed as tumor-promoters. Here, we describe a novel antitumor pathway in which TANs promote IL-12 production by macrophages, leading to type 1 polarization of a subset of unconventional αβ T cell (UTCαβ). Type 1 UTCαβ possess an innate-like phenotype and antitumor potential in vivo. In selected human tumors, neutrophil infiltration is associated with type 1 immunity and better clinical outcome.
AB - Neutrophils are a component of the tumor microenvironment and have been predominantly associated with cancer progression. Using a genetic approach complemented by adoptive transfer, we found that neutrophils are essential for resistance against primary 3-methylcholantrene-induced carcinogenesis. Neutrophils were essential for the activation of an interferon-γ-dependent pathway of immune resistance, associated with polarization of a subset of CD4− CD8− unconventional αβ T cells (UTCαβ). Bulk and single-cell RNA sequencing (scRNA-seq) analyses unveiled the innate-like features and diversity of UTCαβ associated with neutrophil-dependent anti-sarcoma immunity. In selected human tumors, including undifferentiated pleomorphic sarcoma, CSF3R expression, a neutrophil signature and neutrophil infiltration were associated with a type 1 immune response and better clinical outcome. Thus, neutrophils driving UTCαβ polarization and type 1 immunity are essential for resistance against murine sarcomas and selected human tumors. Tumor-associated neutrophils (TANs) have mainly been portrayed as tumor-promoters. Here, we describe a novel antitumor pathway in which TANs promote IL-12 production by macrophages, leading to type 1 polarization of a subset of unconventional αβ T cell (UTCαβ). Type 1 UTCαβ possess an innate-like phenotype and antitumor potential in vivo. In selected human tumors, neutrophil infiltration is associated with type 1 immunity and better clinical outcome.
KW - carcinogenesis
KW - innate immunity
KW - interleukin-12
KW - macrophages
KW - neutrophils
KW - soft tissue sarcomas
KW - tumor immunology
KW - unconventional T cells
UR - http://www.scopus.com/inward/record.url?scp=85068411899&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2019.05.047
DO - 10.1016/j.cell.2019.05.047
M3 - Article
C2 - 31257026
AN - SCOPUS:85068411899
SN - 0092-8674
VL - 178
SP - 346-360.e24
JO - Cell
JF - Cell
IS - 2
ER -